Chemoinformaics analysis of 1-Hexyl-3-methylcyclopentane
| Molecular Weight | 168.324 | nRot | 5 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 25 |
| Exact Molecular Weight | 168.188 | nRing | 1 |
| Solubility: LogS | -3.648 | nHRing | 0 |
| Solubility: LogP | 1.771 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 36.043 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.817 |
| Synth | 4.463 |
| Natural Product Likeliness | 1.507 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.074 |
| Pgp-sub | 0.75 |
| HIA | 0.003 |
| CACO-2 | -4.912 |
| MDCK | 0.0000179 |
| BBB | 0.983 |
| PPB | 0.742824 |
| VDSS | 2.742 |
| FU | 0.238389 |
| CYP1A2-inh | 0.067 |
| CYP1A2-sub | 0.778 |
| CYP2c19-inh | 0.088 |
| CYP2c19-sub | 0.95 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.741 |
| CYP2d6-inh | 0.884 |
| CYP2d6-sub | 0.905 |
| CYP3a4-inh | 0.776 |
| CYP3a4-sub | 0.929 |
| CL | 5.178 |
| T12 | 0.164 |
| hERG | 0.167 |
| Ames | 0.117 |
| ROA | 0.539 |
| SkinSen | 0.163 |
| Carcinogencity | 0.42 |
| EI | 0.007 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.025 |
| Antiviral | Yes |
| Prediction | 0.518214 |